Synapse - Alexander Lesokhin

Results (381)

Presence of PD-1 expressing T cells predicts for inferior overall survival in newly diagnosed multiple myeloma

Meeting Abstract

Gasmi, B.; Smith, E. L.; Dogan, A.; Hsu, M.; Devlin, S.; Pichardo, J. D.; Chung, D. J.; Koehne, G.; Korde, N. S.; Landau, H. J.; more...
Blood (2015)

Fulltext@MSK | Save

Nivolumab in patients (Pts) with relapsed or refractory classical Hodgkin lymphoma (R/R cHL): Clinical outcomes from extended follow-up of a phase 1 study (CA209-039)

Meeting Abstract

Ansell, S.; Armand, P.; Timmerman, J. M.; Shipp, M. A.; Garelik, M. B. B.; Zhu, L. L.; Lesokhin, A. M.
Blood (2015)

Fulltext@MSK | Save

Nivolumab in patients with relapsed or refractory lymphoid malignancies and classical Hodgkin lymphoma: Updated safety and efficacy results of a phase 1 study (CA209-039)

Meeting Abstract

Armand, P.; Timmerman, J.; Lesokhin, A.; Halwani, A.; Millenson, M.; Schuster, S.; Gutierrez, M.; Scott, E.; Cattry, D.; Freeman, G.; more...
Haematologica (2015)

Fulltext@MSK | Save

Pneumonitis with anti-PD-1/PD-L1 therapy

Meeting Abstract

Naidoo, J.; Cunningham, J.; Woo, K. M.; Hellmann, M. D.; Postow, M. A.; Drilon, A. E.; Chaft, J. E.; Lesokhin, A. M.; Segal, N. H.; Callahan, M. K.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

Presence of myeloid-derived suppressor cells (MDSC) in patients with metastatic castration-sensitive and castration-resistant prostate cancer

Meeting Abstract

Autio, K. A.; Wong, P.; Rabinowitz, A.; Yuan, J. D.; Slavin, L. M.; Brennan, R.; DerSarkissian, M.; Mu, Z. Y.; Scher, H. I.; Lesokhin, A. M.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Minimal residual disease in multiple myeloma: Bringing the bench to the bedside

Journal Article

Mailankody, S.; Korde, N.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Stetler-Stevenson, M.; Landgren, O.
Nature Reviews Clinical Oncology (2015)

Fulltext@MSK | Save

T-cell depleted allogeneic hematopoietic stem cell transplantation for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease

Meeting Abstract

Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Giralt, S.
Bone Marrow Transplantation (2015)

Fulltext@MSK | Save

On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation

Journal Article

Lesokhin, A. M.; Callahan, M. K.; Postow, M. A.; Wolchok, J. D.
Science Translational Medicine (2015)

Fulltext@MSK | Save

Gain of chromosome 1q portends worse prognosis in multiple myeloma patients treated with novel agent based induction regimens even after autologous transplantation